These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 25913864)

  • 1. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial drug discovery: recent progress and future directions.
    Calderón F; Wilson DM; Gamo FJ
    Prog Med Chem; 2013; 52():97-151. PubMed ID: 23384667
    [No Abstract]   [Full Text] [Related]  

  • 6. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
    Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches in antimalarial drug discovery.
    Held J; Kreidenweiss A; Mordmüller B
    Expert Opin Drug Discov; 2013 Nov; 8(11):1325-37. PubMed ID: 24090219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches in antimalarial drug discovery and development: a review.
    Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective in antimalarial chemotherapy.
    Kumar A; Katiyar SB; Agarwal A; Chauhan PM
    Curr Med Chem; 2003 Jul; 10(13):1137-50. PubMed ID: 12678807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hits, leads and drugs against malaria through diversity-oriented synthesis.
    Dandapani S; Comer E; Duvall JR; Munoz B
    Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.
    Delves MJ
    Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning in the treatment of malaria and TB.
    Nzila A; Ma Z; Chibale K
    Future Med Chem; 2011 Sep; 3(11):1413-26. PubMed ID: 21879845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.
    Kalaria PN; Karad SC; Raval DK
    Eur J Med Chem; 2018 Oct; 158():917-936. PubMed ID: 30261467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents.
    Starčević K; Pešić D; Toplak A; Landek G; Alihodžić S; Herreros E; Ferrer S; Spaventi R; Perić M
    Eur J Med Chem; 2012 Mar; 49():365-78. PubMed ID: 22321992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.